In a significant move to bolster the regulatory framework of the pharmaceutical sector, the Government of India has invited Dr Hrushikesh Mahapatra, the former Drugs Controller of Odisha, to serve as a resource person for a prestigious national-level training initiative.
The invitation pertains to the 38th Residential Training Programme (RTP) focusing on ‘Inspections and Investigation Techniques’, organized by the Central Drugs Standard Control Organization (CDSCO) in collaboration with the National Institute of Health and Family Welfare (NIHFW).
The three-day intensive programme is scheduled to be held from March 23 to 25, at the NIHFW campus located in Munirka, New Delhi. This high-level workshop is specifically designed for 40 selected officials representing both the CDSCO and various state drugs control departments across the country. The primary objective is to enhance the participants' grasp of statutory powers and procedural provisions under the Drugs and Cosmetics Act and allied legal frameworks.
Dr Mahapatra has been specifically requested to lead a critical session on the opening day, March 23, from 11.30 to 12.30. His presentation will delve into ‘Statutory Powers and Procedural Law’, covering essential legal facets such as the powers of drug inspectors and the intricate search and seizure procedures under Section 95 of the Bharatiya Nagarik Suraksha Sanhita (BNSS). Additionally, he will provide expert insights into the procedure of inspectors under Section 23, as well as the nuances of legal protection and obstruction as defined in Sections 22(3) and 37.
The curriculum of the training extends beyond theoretical law to build practical skills in planning and documenting investigations across diverse regulated sectors. This includes specialized focus areas such as non-sterile manufacturing units, biological products, active pharmaceutical ingredients (APIs), blood centres, and the evolving landscape of e-pharmacies. The programme also aims to improve the capabilities of officials in drafting effective inspection reports and managing non-cooperative units to ensure legally sustainable enforcement.
To facilitate the learning process, the organizers have requested Dr. Mahapatra to submit a brief profile and comprehensive study materials, including a PowerPoint presentation and relevant case studies, at least two to three days in advance. These materials will be distributed to the trainees to provide a robust reference for post-inspection administrative and legal actions.
The coordination of this event is being managed by Dr. Rajesh Kumar of NIHFW and Dr. S. Eswara Reddy, the Joint Drugs Controller (India) at CDSCO. According to Dr. Hrushikesh Mahapatra, this collaboration highlights the government's commitment to maintaining rigorous standards in the pharmaceutical industry through the continuous professional development of its enforcement officers. |